JAK2 and neoplasm: In PDAC, activation of JAK2/STAT3 cell signaling with the participation of REG3G was found to induce immunosuppression by limiting the antigenicity of tumor cells, suppressing CD8+ cell function, causing variable expression of Th2 cytokines and increasing the proliferation of tumor cells [208].